✦ LIBER ✦

Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy

✍ Scribed by I. Garassino; G. Gullo; S. Orefice; L. Tondulli; G. Masci; P. Salvini; M. Eboli; L. Di Tommaso; L. Giordano; M. Alloisio; M. Roncalli; A. Santoro

Book ID: 113507121
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 256 KB
Volume: 18
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2009.07.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased Risk of Locoregional Recurrenc

Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy

✍ Bellon, J.R.; Harris, J.R. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Overexpression of activated phospholipas

Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy

✍ Rossano Lattanzio; Marco Marchisio; Rossana La Sorda; Nicola Tinari; Marco Falas 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 977 KB

389 PUBLICATION Suggestions for follow-u

389 PUBLICATION Suggestions for follow-up (FU) strategies according to the risk of recurrence in patients with T1N0M0 breast cancer (BC): a single-institution experience

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Integration of risk factors to allow pat

Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients

✍ William C. Wood 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 645 KB

The selection of patients with axillary lymph node-negative breast cancer who should receive adjuvant therapy today is confused by an expanding arsenal of putative prognostic factors. The size of the primary tumor remains the dominant factor in sorting among this group of patients, with general agre

Trends in sun exposure knowledge, attitu

Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996",June K. Robinson; Darrell S. Rigel; Rex A. Amonette 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80119-3,CME examination," 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80118-1,Antimicrobial agents for the dermatologist. I. β-Lactam antibiotics and related compounds,Marcia E. Epstein; Maria Amodio-Groton; Neil S. Sadick 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80140-5,Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis,P. Kullavanijaya; S. Reangchainam; R. Ungpakorn 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80143-0,Effect of topical pramoxine on experimentally induced pruritus in humans,Gil Yosipovitch; Howard I. Maibach 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80149-1,Treatment of psoriasis with the pulsed dye laser,S.W. Lanigan; G.A. Katugampola 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80147-8,Response rates in photopheresis therapy for cutaneous T-cell lymphoma,Herschel S. Zackheim; Mohammed Kashani-Sabet 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80136-3,Keratosis lichenoides chronica: Response to topical calcipotriol,Marcelo H. Grunwald; Dafna Hallel-Halevy; Boaz Amichai 01909622,37,1997,1,10.1016/s0190-9622(97)70209-3,Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas,Rob C. Beljaards; Peter Van Beek; Rein Willemze 01909622,37,1997,1,10.1016/s0190-9622(97)70208-1,A novel nonepidermolytic palmoplantar keratoderma: A clinical and histopathologic study of six cases,Cynthia M. Magro; Lynn A. Baden; Arthur N. Crowson; Paul E. Bowden; Howard P. Baden 01909622,37,1997,1,10.1016/s0190-9622(97)70216-0,"Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

✍ Gerald D. Weinstein; Gerald G. Krueger; Nicholas J. Lowe; Madeleine Duvic; David 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 765 KB